Hosted on MSN8mon
Senator slams GlaxoSmithKline over cost of asthma inhalers
or COPD. Many of those patients purchase inhalers on a monthly basis and rely on them to help them breathe. Democrats have framed the high cost of inhalers as a symptom of America’s broader ...
Medical Xpress17d
Study compares single-inhaler triple therapies for treatment of COPD
DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...
pharmaphorum6y
AZ boosted by COPD triple inhaler results
AstraZeneca may mount a challenge to GlaxoSmithKline’s three-in-one inhaler for chronic obstructive pulmonary disease (COPD) after a late-stage trial success. AZ’s single inhaler, PT010 ...
Hosted on MSN20d
Environmentally Friendlier COPD Inhaler May Also Be More Effective
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...
thecardiologyadvisor.com4d
In COPD, CV Events Increase With Use of Single-Inhaler Triple Therapy
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
News Medical on MSN13d
Study finds no clinical advantage of budesonide inhaler over fluticasone in COPD
A study compares budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol, revealing insights on COPD ...